Skip to main content
Clinical Trials/NCT06975735
NCT06975735CompletedNot Applicable

Does the Transversalis Fascia Plane Block Work Better Than the Transversus Abdominis Plane Block for Relieving Pain After a Robotic-assisted Partial Prostatectomy?

TC Erciyes University1 site in 1 country108 target enrollmentStarted: May 25, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
108
Locations
1
Primary Endpoint
Reducing patient-controlled analgesic consumption

Study Overview

Brief Summary

Regional anesthetics, nerve blocks, and interfascial blocks are becoming more common in many types of surgery to help with pain after surgery. Most clinicians concur with the importance of reducing postoperative pain scores and facilitating early discharge. The transversalis fascia plane block (TFP) and transversus abdominis plane block (TA), which are done from the side of the abdomen, have been proven to be very useful in surgeries related to women's health, weight loss, and the colon. Research on the effectiveness of both procedures in robot-assisted laparoscopic prostatectomies (RALP) is insufficient. The aim was to see if using a transversalis fascia plane block (TFP) or a transversus abdominal plane (TAP) block with 0.25% bupivacaine helped reduce pain, speed up recovery, and shorten hospital stays for men undergoing robot-assisted radical prostatectomy (RALP).

Detailed Description

Regional anesthetics, nerve blocks, and interfascial blocks are becoming more common in many types of surgery to help with pain after surgery. Most clinicians concur with the importance of reducing postoperative pain scores and facilitating early discharge. The transversalis fascia plane block (TFP) and transversus abdominis plane block (TA), which are given from the side of the abdomen, have been found to be very useful in surgeries related to women's health, weight loss, and the colon. Research shows that both procedures are ineffective in robot-assisted laparoscopic prostatectomies (RALP).

In this study, doctors will start general anesthesia using propofol and rocuronium as usual and keep it going with a mix of 4-6% desflurane with oxygen, remifentanil, and rocuronium given through an IV.

All procedures will be conducted within the framework of an observational clinical research protocol, and patients will not be subjected to any procedures outside of routine practices.

Before starting the study, patients will be thoroughly informed, and their written consent will be obtained. The study is planned to start in May 2025.

Patients will be examined in the anesthesia outpatient clinic for preoperative evaluation. Demographic data (age, gender, ASA score, height, weight, BMI, and comorbidities) will be recorded in the preoperative patient evaluation form.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •American Society of Anesthesiologists (ASA) Class I or II
  • •Having regular preoperative visits

Exclusion Criteria

  • •Patients classified as ASA III or IV,
  • •Patients with coagulopathy
  • •Those with a history of allergies
  • •Significant Cardiac Disorders (Coronary Artery Disease, Arrhythmia, Electrocardiography Anomaly, Heart Failure, etc.)
  • •1. Those with bleeding diathesis and those receiving anticoagulant therapy
  • •Those with a history of carotid artery stenosis,
  • •Cardiovascular disease,
  • •Hipertansiyon,
  • •Chronic obstructive pulmonary disease,
  • •Patients with a heart rhythm outside the sinus
  • •Patients with a history of cerebrovascular disease
  • •Alcoholism or psychiatric illness
  • •Those with diabetes,
  • •Contraindicated for TAP and TFP Block
  • •Those with drug allergies

Arms & Interventions

Control Group

No Intervention

Not receiving TAP or TFP

TAP Group

Active Comparator

Receiving TAP 20 ml bupivacaine 0.25%

Intervention: TAP Plane Block (Procedure)

TFP Group

Active Comparator

Receiving TFP 20 ml bupivacaine 0.25%

Intervention: TFP Block (Procedure)

Outcomes

Primary Outcomes

Reducing patient-controlled analgesic consumption

Time Frame: From the patient's anesthesia induction in the operating room to the postoperative 24. hours

The time to first analgesic request in the postoperative period

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kudret Dogru

Prof. Dr. (MD)

TC Erciyes University

Study Sites (1)

Loading locations...

Similar Trials

Does the TAP Block Work Better Than the... | Clinical Trial